Work

ChemInform Abstract: Phenylalanine Derivatives as GPR142 Agonists for the Treatment of Type II Diabetes.

Year: 2013

Type: article

Source: ChemInform

DOI: 10.1002/chin.201307183

Authors: Xiaohui Du, et al. et al.

Institution: Amgen (United States)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2911580838

FWCI:

Cites: 1

Cited by:

Related to: 10